P53 EXPRESSION IN PATIENTS WITH MYELODYSPLASTIC SYNDROME AT DIAGNOSIS AND FOLLOWING TREATMENT WITH AZACITIDINE

被引：0
|
作者：
Maung, S. [1 ]
Strahan, N. [1 ]
Desmond, R. [1 ]
McHugh, J. [1 ]
Burke, C. [1 ]
O'Loughlin, J. [2 ]
Jeffers, M. [2 ]
Enright, H. [1 ]
机构：
[1] Tallaght Hosp, Trinity Coll, Sch Med, Haematol, Dublin, Ireland
[2] Tallaght Hosp, Trinity Coll, Sch Med, Cellular Pathol, Dublin, Ireland
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1225
引用
收藏
页码：491 / 491
页数：1
相关论文
共 50 条
  • [41] EVALUATION OF P53 PROTEIN EXPRESSION IN MYELODYSPLASTIC PATIENTS: PROGNOSTIC IMPACT IN A SINGLE CENTRE EXPERIENCE
    Ricco, A.
    Napoli, A.
    Carluccio, P.
    Rossi, A. V. Russo
    Pasciolla, C.
    Leo, M.
    Franco, A.
    Daraia, B.
    Carluccio, V.
    Cellamare, A.
    Specchia, G.
    HAEMATOLOGICA, 2015, 100 : 720 - 720
  • [42] PROGNOSTIC IMPACT OF P53 PROTEIN EXPRESSION IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES: A SINGLE CENTRE EXPERIENCE
    Ricco, A.
    Napoli, A.
    Carluccio, P.
    Rossi, A. V. Russo
    Daraia, B.
    Maiorano, E.
    Specchia, G.
    LEUKEMIA RESEARCH, 2015, 39 : S83 - S84
  • [43] Late Hematological Improvement of Myelodysplastic Syndrome Following Treatment with 5-Azacitidine Therapy
    Takaoka, Kensuke
    Hangaishi, Akira
    Ito, Ayumu
    Morioka, Takehiko
    Kida, Michiko
    Usuki, Kensuke
    INTERNAL MEDICINE, 2014, 53 (19) : 2241 - 2243
  • [44] Azacitidine is effective for the treatment of myelodysplastic syndrome and accompanied Sweet syndrome
    Lin, Che-Hung
    Yeh, Su-Peng
    Lin, Tze-Yi
    ANNALS OF HEMATOLOGY, 2015, 94 (11) : 1925 - 1926
  • [45] Outcome of acute myeloid leukaemia following myelodysplastic syndrome after azacitidine treatment failure
    Prebet, Thomas
    Gore, Steven D.
    Thepot, Sylvain
    Esterni, Benjamin
    Quesnel, Bruno
    Rauzy, Odile Beyne
    Dreyfus, Francois
    Gardin, Claude
    Fenaux, Pierre
    Vey, Norbert
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 (06) : 764 - 766
  • [46] Azacitidine is effective for the treatment of myelodysplastic syndrome and accompanied Sweet syndrome
    Che-Hung Lin
    Su-Peng Yeh
    Tze-Yi Lin
    Annals of Hematology, 2015, 94 : 1925 - 1926
  • [47] Neutrophilic panniculitis following azacitidine treatment for myelodysplastic syndromes
    Kim, In-Ho
    Youn, Jae-Ho
    Shin, Seung-Hwan
    Yahng, Seung-Ah
    Lee, Sung-Eun
    Kwon, Jae-Cheol
    Lee, Dong-Gun
    Park, Kyung-Shin
    Choi, Moon-Hyung
    Jung, Seung-Eun
    Kim, Yoo-Jin
    LEUKEMIA RESEARCH, 2012, 36 (07) : E146 - E148
  • [48] p53 and MDM-2 expression in myelodysplastic syndrome (MDS) following autologous bone marrow transplantation (auto-BMT) for lymphoma
    Brynes, RK
    Wilson, CS
    Kim, AB
    McCourty, A
    LABORATORY INVESTIGATION, 1997, 76 (01) : 703 - 703
  • [49] Changes in p53 Expression By Immunohistochemistry during Azacitidine Therapy in Patients with MDS Can Predict Overall Prognosis
    Maung, Su Wai
    Strahan, Niamh
    O'Byrne, Philomena
    O'Dowd, Sarah
    O'Loughlin, John
    Desmond, Ronan
    McHugh, Johnny
    Jeffers, Michael
    Enright, Helen
    BLOOD, 2015, 126 (23)
  • [50] OUTCOME OF 5-AZACITIDINE AND DECITABINE TREATMENT IN ELDERLY PATIENTS WITH MYELODYSPLASTIC SYNDROME
    Nam, S.
    Lim, T.
    Kim, B.
    HAEMATOLOGICA, 2013, 98 : 588 - 588
12345